 |
|
New therapies mean HIV patients gain longer lives, face new challenges
May 18, 2009New HIV therapies have prolonged lives and improved health for patients with HIV, but the treatments have also brought the longer-term effects of the disease into sharper focus.
Patients with HIV are not only about twice as likely to smoke as HIV-negative individuals, they are also more susceptible to the detrimental effects of smoking and tend to suffer a swifter decline in lung function, according to new research. Syed Kadri, medical student at Ohio State University Medical Center will present new research documenting this decline among HIV-positive individuals on Sunday, May 17, at the 105th International Conference of the American Thoracic Society in San Diego.
"Early in the epidemic, HIV was a different disease-with few effective drugs, the best that an HIV- positive patient could hope for was a relatively painless death after a brief period," said Mr. Kadri. "The long-term effects of HIV were therefore fairly obvious: death. But with the advent of a new class of anti-retroviral drugs called 'highly active anti-retroviral therapy,' or HAART, the clinical picture of HIV has changed. The disease has gone from being an automatic death sentence to a chronic condition, and like all chronic conditions, it brings with it other complications that can seriously affect the lives of those who have it."
Mr. Kadri and colleagues are directing a prospective study to evaluate declines in lung function among HIV-positive patients. The patients, mostly men in their 40s, half of whom were smokers, were assessed at baseline for two measures of respiratory status, FEV1 and DLCO, and had been followed for two years at the time of reporting. FEV1 is a measure of expiratory flow in one second, a standard gauge of lung capacity, whereas DLCO is a measurement of diffusing capacity of the lungs and is decreased in patients with emphysema.
At the end of two years, the 63 patients displayed marked declines in lung function, going from an average FEV1 of 88% predicted to 83.2% and a DLCO of 77.6 to 70.0. "This is the type of decline you might expect to see in elderly individuals who have a long history of smoking," said Mr. Kadri. "These results indicate that HIV-positive patients are more susceptible to lung-related problems than HIV-negative individuals and that HIV-positive smokers are even more susceptible to developing early emphysema. We don't know when these differences begin to manifest in HIV-positive individuals who smoke, but the severity is likely a function of the time that they have lived with the disease."
The researchers have begun a new leg of the study, to analyze the effects of smoking cessation in the same cohort as those in the current study. "We hope this next phase will show us whether lung function improves with smoking cessation in HIV-positive individuals and what factors are associated with successful cessation," said Mr. Kadri. "Clinically, this study shows that HIV patients need to quit smoking, which could be a difficult task given their higher prevalence of smoking. Physicians treating patients with HIV should be aware that they are at much higher risk for emphysema, and counsel them more about smoking cessation."
American Thoracic Society
Mr. Kadri and colleagues are directing a prospective study to evaluate declines in lung function among HIV-positive patients. The patients, mostly men in their 40s, half of whom were smokers, were assessed at baseline for two measures of respiratory status, FEV1 and DLCO, and had been followed for two years at the time of reporting. FEV1 is a measure of expiratory flow in one second, a standard gauge of lung capacity, whereas DLCO is a measurement of diffusing capacity of the lungs and is decreased in patients with emphysema.
At the end of two years, the 63 patients displayed marked declines in lung function, going from an average FEV1 of 88% predicted to 83.2% and a DLCO of 77.6 to 70.0. "This is the type of decline you might expect to see in elderly individuals who have a long history of smoking," said Mr. Kadri. "These results indicate that HIV-positive patients are more susceptible to lung-related problems than HIV-negative individuals and that HIV-positive smokers are even more susceptible to developing early emphysema. We don't know when these differences begin to manifest in HIV-positive individuals who smoke, but the severity is likely a function of the time that they have lived with the disease."
The researchers have begun a new leg of the study, to analyze the effects of smoking cessation in the same cohort as those in the current study. "We hope this next phase will show us whether lung function improves with smoking cessation in HIV-positive individuals and what factors are associated with successful cessation," said Mr. Kadri. "Clinically, this study shows that HIV patients need to quit smoking, which could be a difficult task given their higher prevalence of smoking. Physicians treating patients with HIV should be aware that they are at much higher risk for emphysema, and counsel them more about smoking cessation."
American Thoracic Society
HIV Current Events and HIV News RSSMany pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission.
An atomic-level look at an HIV accomplice
Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Hoping for a fluorescent basket case
Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem.
Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design
A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
Indiana U. at APHA: Studies about why men and women use lubricants during sex
An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.
More HIV Current Events and HIV News Articles
 |
100 Questions and Answers About HIV and AIDS by Joel Gallant (Author) |
 |
The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) by Brett Grodeck (Author), M.D. Daniel S. Berger (Foreword) This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans. |
 |
HIV Essentials 2010 by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author) HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications. Topics include: HIV diagnosis, evaluation, treatment and prevention; Opportunistic infections and other HIV Complications; Treatment of HIV and pregnancy; Antiretroviral drug summaries; Post-exposure Prophylaxis; New section to each drug summary called "How Supplied" describes the commercially available dosage forms for all the ARV's |
 |
Home Access HIV - 1 Express Test System - 1 ea by Home Access Next Day Results* Contains one single-use sample collection kit |
 |
Living with HIV: A Patient's Guide by Mark Cichocki (Author) This helpful guide offers a wealth of information for individuals who have been diagnosed with HIV and for people caring for HIV positive friends and loved ones. It covers the entire HIV lifespan, from prevention to diagnosis and beyond. Valuable tips help the reader make the best decision when choosing a doctor, finding and adhering to the right medication regimen, and, if necessary, making end-of-life plans. All aspects of HIV/AIDS are discussed, including opportunistic and associated infections, dental care, exercise and nutrition, substance use and abuse, and emotional treatment. |
 |
The Naked Truth: Young, Beautiful, and (HIV) Positive by Marvelyn Brown (Author), Courtney Martin (Author) The surprisingly hopeful story of how a straight, nonpromiscuous, everyday girl contracted HIV and how she manages to stay upbeat, inspired, and more positive about life than ever before At nineteen years of age, Marvelyn Brown was lying in a stark white hospital bed at Tennessee Christian Medical Center, feeling hopeless. A former top track and basketball athlete, she was in the best shape of her life, but she was battling a sudden illness in the intensive care unit. Doctors had no idea what was going on. It never occurred to Brown that she might be HIV positive. Having unprotected sex with her Prince Charming had set into swift motion a set of circumstances that not only landed her in the fight of her life, but also alienated her from her community. Rather than give... |
 |
Absolutely Positive Directed By: Peter Adair Also With: Janet Cole (Cinematographer), Peter Adair (Cinematographer), Peter Adair (Writer) Ten years following its ground-breaking debut at Sundance, the landmark film that first humanized the face of AIDS is now available in this special 10th Anniversary Edition. Simultaneously heart-wrenching and life affirming, ABSOLUTELY POSITIVE is an hon |
 |
HIV and the Pathogenesis of AIDS, 3rd Edition by Jay A. Levy (Author) The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed. Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and... |
 |
HIV/AIDS: A Very Short Introduction (Very Short Introductions) by Alan Whiteside (Author) HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means... |
 |
HIV GIANT MICROBE by Giant Microbes H.I.V. kills CD4 cells, or T-helper cells ? Once the immune system is compromised, a person develops AIDS (acquired immuno-deficiency syndrome) ? H.I.V. is most commonly transmitted by sexual contact with an infected person ? Insect bites and sweat carry almost no risk of transmission ? Studies show that drying H.I.V. infected fluids can reduce viral presence by 90-99% ? There is no vaccine for H.I.V. and no cure for AIDS |
| © 2009 BrightSurf.com |